We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Open Orphan Plc | LSE:ORPH | London | Ordinary Share | GB00B9275X97 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 10.00 | 9.50 | 10.50 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
04/12/2020 11:24 | There's been some steady buying this morning. Nothing spectacular but just steady continuous buying. Either there is a large sell been held back or a small jump up can be expected before the end of today. | wreckage | |
04/12/2020 11:21 | Yes come on Cathal get that deal signed and sealed | malcolmmm | |
04/12/2020 11:09 | It’s now about time he brought us one of the big deals (wearables, Immutuex etc etc) instead of talking about them in podcasts Without doubt we also need authorisation for the CHIMS Only then will see some real share price action Happy to be holding but good real solid news needed now not just good old blarney on yet another podcast imho | judijudi | |
04/12/2020 11:08 | Warranty, Yump hasn't commented on orph recently, he came to post that the covid drug hasn't been rushed. So i don't know what yu mean that there's some truth about orph in what he said. He said 10 months isn't rushed because the usual 10 year phase 3 testing is due to getting funding and waiting for various unspecified things. So a 10 year study is actually a 10 month study with 9 years 2 months simply wasting time for some reason, according to him. | pierre oreilly | |
04/12/2020 11:01 | Warranty, everyone knows there are no certainties on the stock market. That's about the tenth time various posters have told you that, yet you still keep posting it as if all of us here are saying everything is certain. btw, this isn't 'jumping on you because you're not posting positively', it's a simple response to what you posted. | pierre oreilly | |
04/12/2020 11:01 | Warranty I dont think anyone is shouted down initially, posters are asked to put up evidence for their POV then when they fail they are shouted at for putting forward unsubstantiated points aka deramping. Cargo did not even know how OPRH made money! | pogue | |
04/12/2020 10:52 | I have to say that there is an element of truth in what Cargo and Yump are saying. Anything which is remotely negative or questioning is immediately jumped on by some on here. I myself, despite being a positive and confident owner, have been criticised for stating my potential concerns and been harangued for it. Nothing is certain when investing, certainly not when either big business or government authorities are concerned and there can be no guarantees that Orph will receive authorisation for COVID CHIMs and nor can there be any certainty that a wearables deal will be delivered, or at a price that will significantly be reflected in the share price. Equally there is no certainty that Orph will either find a buyer for or float Immutex. These are all probables but until we actually see some clarification, the share price will remain where it is, reflecting the current value of the company on what we do know. All of us holders have bought into the story, CF himself and the huge potential here but I personally listen to all views and make my mind up who I believe. Others can do it differently, whatever floats your boat. | warranty | |
04/12/2020 10:51 | thanks wassapper 8966 | 666james | |
04/12/2020 10:44 | Shares events are sponsored by AJ Bell. Same thing | wassapper | |
04/12/2020 10:33 | Lhoskins lucky you said that I had it in my diary as AJ Bell next week | pogue | |
04/12/2020 10:24 | Thats right.its a ticking time bomb. | lhoskins | |
04/12/2020 10:17 | CF presenting next week | wassapper | |
04/12/2020 09:15 | NIHR Vaccine Statement ‘Different vaccines work in different ways and we still need to collect important information about which vaccines work best, and are best for different groups of people, and on exactly how effective they are at, for example, preventing severe infection, preventing infection as a whole, preventing transmission etc. We also need information on matters such as the best way to use vaccines, the number of doses, and to check long term that there are no safety concerns…. ….We need volunteers to join new studies and existing studies are not yet complete, and we need the long term data to help us understand how best to use the vaccines, which are most effective and to give information on the levels of effectiveness, as well as reassurance on long term safety of them.’ hxxps://bepartofrese | trader_3 | |
04/12/2020 08:54 | M5 I tried, never know he may have had some knowledge or alternative view, sometimes though first impressions are right especially on ADVFN lol. | pogue | |
04/12/2020 08:47 | Just picked up another 27,635. :) :) :) | bobsworth | |
04/12/2020 08:32 | What about the Imperial College vaccine? Researchers at Imperial have developed a candidate which, when injected, will deliver the genetic instructions to muscle cells to make the SARS-CoV-2 spike surface protein. This should provoke an immune response and create immunity to the virus. The Imperial human challenge trial is being run by hVivo, a spin-off company from Queen Mary University of London. Already roughly 2,000 people have signed up to take part in challenge studies in Britain through the group 1Day Sooner. Those testing the vaccine will be given the jab and will then wait a month for antibodies to build. The volunteers will then be exposed to the virus. Rather than giving people a weakened form of the illness, the Imperial vaccine instead uses synthetic strands of genetic code based on the virus' genetic material | malcolmmm | |
04/12/2020 08:02 | Testing going nowhere methinks | molatovkid | |
04/12/2020 06:59 | The company has a full order book is growing and is profitable. Recognised officially as the world leader in its field with many years of experience and has the worlds biggest data base on virus deseass ,most here are making money .Why argue the toss with jealous trolls or shorters who obviously know little about the company. Best to ignore as a lot did when these were 6p12p,16p etc Techinvest out soon ,they had them as a buy last month. | malcolmmm | |
04/12/2020 06:15 | 100% supporter, because I am invested in ORPH. Why would anyone invest in a company if they have not done their research and why would anyone who has done their research and not happy with the company still be posting negatively on a bulletin board unless they have ulterior motives? | curnic1 | |
04/12/2020 00:45 | How much did you lose on Venn? | discojames | |
03/12/2020 23:50 | Well that will really encourage other investors won’t it pogue ? Crikey you are so defensive - paranoia as soon as anyone tries to have a discussion. Pathetic. None of you seem to have any recognition that this is one great big echo chamber. It will actually serve you right if it doesn’t turn out well for you. You’d better start another thread where you can block me, as I’ve decided not to go after all. You need to be called out on the truly ignorant way you post. Good luck to those of you who can actually inhabit here and aren’t blindly 100% supporters. | yump |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions